ATOSSA THERAPEUTICS, INC. (ATOS) Capital expenditures 2018–2025
ATOSSA THERAPEUTICS, INC. (ATOS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$23,000FY2025 · since FY2018: $110,906 → $23,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $23,000 | +21.1% |
| FY2024 | $19,000 | +35.7% |
| FY2023 | $14,000 | -48.1% |
| FY2022 | $27,000 | +200.0% |
| FY2021 | $9,000 | +0.0% |
| FY2020 | $9,000 | +18.0% |
| FY2019 | $7,625 | -93.1% |
| FY2018 | $110,906 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice